A forum focused on how big data and precision medicine can help “crack the code” on heart disease and stroke advances will be held Thursday in New York City.

Leaders from industry, investment and academia will meet at the American Heart Association/American Stroke Association’s Heart and Stroke Innovation Forum to examine ways to improve patient care and lower heart disease and stroke costs, organizers said. The annual event will be held at the Alexandria Center for Life Science.

More than 92 million American adults are living with some form of cardiovascular disease or the effects of stroke, and direct and indirect costs are estimated at about $316 billion, according to the AHA.

“Investment and innovation are at the foundation of medical advances that improve patient care,” said Craig Granowitz, M.D., Ph.D., an event speaker and chief medical officer at Amarin, a biopharmaceutical company. “The Heart and Stroke Innovation Forum is an outstanding collaborative meeting place that shows how payers, providers, pharma companies and academic medical centers work together to impact patient lives.”

Attendees can learn about cutting-edge tools for preventing heart disease and delivering stroke care. A stroke survivor will give her perspective on participating in My Research Legacy, a pilot study of heart attack and stroke survivors.